Blue Cell Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 39981610
Ole Maaløes Vej 3, 2200 København N
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | -2 069.78 | - 843.70 | 852.13 | - 741.53 |
| Employee benefit expenses | -12 007.23 | -8 474.46 | -11 642.95 | -14 195.72 |
| Other operating expenses | - 873.82 | -5 845.13 | -3 735.73 | -2 986.32 |
| Total depreciation | - 218.68 | - 273.58 | - 335.32 | |
| EBIT | -14 950.83 | -15 381.97 | -14 800.13 | -18 258.89 |
| Other financial expenses | -41.07 | -51.45 | -64.46 | -3.51 |
| Pre-tax profit | -14 991.90 | -15 433.43 | -14 864.59 | -18 262.41 |
| Income taxes | 965.00 | 1 192.02 | 2 294.63 | 2 974.03 |
| Net earnings | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 602.06 | 328.48 | 269.50 | ||
| Tangible assets total | 602.06 | 328.48 | 269.50 | ||
| Investments total | 56.24 | 103.80 | 82.60 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 138.84 | ||||
| Prepayments and accrued income | 6.46 | 118.65 | 36.77 | ||
| Current other receivables | 2.00 | 18 793.54 | 576.14 | 1 477.86 | 3 164.73 |
| Current deferred tax assets | 965.00 | 2 157.02 | 4 451.65 | 2 973.95 | |
| Short term receivables total | 2.00 | 19 758.54 | 2 739.62 | 6 187.00 | 6 175.45 |
| Cash and bank deposits | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | |
| Cash and cash equivalents | 9 745.55 | 10 606.82 | 4 005.38 | 3 631.63 | |
| Balance sheet total (assets) | 2.00 | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 2.00 | 40.00 | 40.00 | 43.13 | 47.46 |
| Share premium account | 29 962.00 | ||||
| Other reserves | 16 000.00 | ||||
| Retained earnings | -6 199.28 | 26 682.62 | 22 438.08 | 23 659.95 | |
| Profit of the financial year | -14 026.90 | -14 241.41 | -12 569.96 | -15 288.37 | |
| Shareholders equity total | 2.00 | 25 775.82 | 12 481.21 | 9 911.25 | 8 419.03 |
| Non-current liabilities total | |||||
| Current trade creditors | 963.40 | 885.33 | 327.89 | 668.23 | |
| Other non-interest bearing current liabilities | 514.88 | 638.19 | 385.51 | 1 071.92 | |
| Accruals and deferred income | 2 250.00 | ||||
| Current liabilities total | 3 728.27 | 1 523.53 | 713.41 | 1 740.15 | |
| Balance sheet total (liabilities) | 2.00 | 29 504.10 | 14 004.74 | 10 624.66 | 10 159.19 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.